Results 11 to 20 of about 108,435 (311)
INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRIC RHEUMATOLOGY PRACTICE
Вопросы современной педиатрии, 2015 Modern successful treatment of rheumatic diseases is impossible without the use of intravenous immunoglobulin. The use of intravenous immunoglobulin is based on strict indications developed as a result of long-term multicenter controlled studies.
E. I. Alexeeva +2 more
doaj +1 more source
Annals of Pediatric Cardiology, 2021 Background: Standard first-step therapy for Kawasaki disease consists of Intravenous immunoglobulin and high dose Aspirin (80-100 mg/kg/day). The standard dose of Intravenous immunoglobulin (2gr/kg) is strongly effective in reducing the risk of coronary ...
Farima Sanati +3 more
doaj +1 more source
Journal of Medical Case Reports, 2019 Background Immune thrombocytopenia is an acquired autoimmune disease. Recently, there has been evidence of thrombotic risk in patients with immune thrombocytopenia, but the mechanism is still inconclusive.
Tarinee Rungjirajittranon +1 more
doaj +1 more source
Haematologica, 2014 Intravenous immunoglobulin replacement therapy represents the standard treatment for hypogammaglobulinemia secondary to B-cell lymphoproliferative disorders. Subcutaneous immunoglobulin infusion is an effective, safe and well-tolerated treatment approach
Nicolò Compagno +3 more
doaj +1 more source
Case Reports in Dermatology, 2023 This case report discusses immunoglobulin-induced erythema multiforme (EM), a rare and understudied condition that requires further investigation. The report presents the case of a 69-year-old woman with a history of chronic lymphocytic leukemia who ...
Angelina Konovalova +7 more
doaj +1 more source
Nepalese Medical Journal, 2019 Introduction: Intravenous Immunoglobulin is an approved therapy for Guillain Barre Syndrome. Our objective is to understand the management and outcome in Guillain Barre Syndrome patients treated with Immunoglobulin. Materials and Methods: All consecutive
Rajeev Ojha, Ragesh Karn
doaj +1 more source
Nephrotoxicity of intravenous immunoglobulin [PDF]
QJM, 2000 Individual case reports have documented nephrotoxicity of intravenous immunoglobulin (IVIG) preparations, but the true incidence of renal dysfunction is unknown and many data sheets do not include renal impairment as a side-effect of these preparations.
J B, Levy, C D, Pusey
openaire +2 more sources
Clinics, 2009 INTRODUCTION: Common variable immunodeficiency is characterized by defective antibody production and recurrent pulmonary infections. Intravenous immunoglobulin is the treatment of choice, but the effects of Intravenous immunoglobulin on pulmonary defense
Andrea Cristina Pereira +6 more
doaj +1 more source
Rescue treatment in patients with poorly responsive Guillain–Barre syndrome
SAGE Open Medicine, 2019 Objectives: To evaluate the effectiveness of rescue treatment (intravenous immunoglobulin or plasma exchange) in patients with Guillain–Barre syndrome who did not respond or deteriorated after the initial management with intravenous immunoglobulin ...
Ayman Mahmoud Alboudi +7 more
doaj +1 more source
Intravenous Immunoglobulin Induced Transaminitis
Cureus, 2023 Intravenous immunoglobulin (IVIG) is a common therapeutic modality used in immune-mediated neuropathy. While the therapeutic benefits are well known, adverse reactions have been reported. One such adverse event, though rare, is transaminitis, which appears to be a transient and a self-limiting adverse reaction.
Vijaya Prakash, Aviraag +3 more
openaire +2 more sources